Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers. Editor, Dey N. PloS one. 2022; 17:e0256788..
Novel molecular mechanisms in Alzheimer's disease: The potential role of DEK in disease pathogenesis. Frontiers in Aging Neuroscience. 2022; 14:1018180..
In silico gene expression and pathway analysis of DEK in the human brain across the lifespan. European Journal of Neuroscience. 2022; 56:4720-4743..
Defective transcription elongation in human cancers imposes targetable proteotoxic vulnerability. Translational Oncology. 2022; 16:101323..
Loss of DEK Expression Induces Alzheimer's Disease Phenotypes in Differentiated SH-SY5Y Cells. Frontiers in Molecular Neuroscience. 2020; 13:594319..
IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer models. Editor, Lebedeva IV. PloS one. 2020; 15:e0229801..
2019; 134:4647.. The Small Molecule IODVA1 Inhibits the Rac Guanine Nucleotide Exchange Factor Vav3 and Overcomes TKI-Resistance in Ph+(BCR-ABL1) B-ALL. Blood.
Optical Redox Imaging Detects the Effects of DEK Oncogene Knockdown on the Redox State of MDA-MB-231 Breast Cancer Cells. Molecular Imaging and Biology. 2019; 21:410-416..